Nexteras technology offers a highly versatile and innovative platform that finds its application in a broad array of fields leaning on protein engineering and evolution, such as life sciences, IVD, drug discovery and lead optimization. Nexteras strategy is to build on our true uniqueness and core strengths to differentiate from competition and maximize value creation. Thus, the company focuses on high-resolution target discovery and lead candidate development in HLA class II associated mechanisms. For all leads developed by Nextera, a companion diagnostic will also be included given the nature of our applied discovery tools.

The Institute Pasteur is a private, non-profit foundation. Its mission is to help prevent and treat diseases, mainly those of infectious origin, through research, teaching, and public health initiatives.The Institut Pasteur is a research center of international renown ideally located in the very heart of Paris. Each year the institute hosts a multitude of scientific and medical conferences and meetings as well as events on a variety of themes.

Ajinomoto Co. is a global manufacturer of high-quality seasonings, processed foods, beverages, amino acids, pharmaceuticals and specialty chemicals. For many decades Ajinomoto Co. has contributed to food culture and human health through wide-ranging application of amino acid technologies. Today, the company is becoming increasingly involved with solutions for improved food resources, human health and global sustainability. Founded in 1909 and now operating in 26 countries, Ajinomoto Co. had net sales of JPY 1,197.3 billion (USD 15.1 billion) in fiscal 2011. The Ajinomoto Group Standards of Business Conduct (hereinafter the "Standards of Conduct") describe the conduct that every member of the Ajinomoto Group must understand and practice every day in order to implement the Ajinomoto Group Philosophy in accordance with the Ajinomoto Group Way. The Standards of Conduct also represent the commitments made to all stakeholders by Ajinomoto Group companies. Ajinomoto aim to be "a group of companies that contributes to human health globally" by continually creating unique value to benefit customers. To become a global group of food companies centered on the world's No. 1 seasoning business. To become a global group of aminoscience companies that contributes to humankind with the world's No. 1 amino acid technology. To become a group of health-promoting companies with a scientific approach to good taste and health.

The Eli and Edythe L. Broad Institute of MIT and Harvard (/ˈbroʊd/), often referred to as the Broad Institute, is a biomedical and genomic research center located in Cambridge, Massachusetts, United States. The institute is independently governed and supported as a 501(c)(3) nonprofit research organization under the name Broad Institute Inc., and is partners with Massachusetts Institute of Technology, Harvard University, and the five Harvard teaching hospitals.

ZymoGenetics is focused on the discovery, development, and early manufacture of therapeutic proteins. ZymoGenetics is a fully-integrated research and development organization with a broad range of skills and technologies, including scientific computing, molecular and cellular biology, protein chemistry, antibody generation and engineering, clinical development and operations, regulatory affairs, quality, drug formulation, process development and protein manufacturing.

The Carlos Slim Health�Institute is a non profit�organization devoted to generate�solutions to solve�the main health issues afflicting�Latin America and Mexico�s most�vulnerable population.

Institut de Recherche pour le Développement operates as a scientific and technical public institution which provides information, expertise, support and training in production performance. It performs research centered on the relationship between human beings and its environment in intertropical areas. In that context the IRD implements research projects on sleeping sickness and the vectors transmitting the disease. The company is headquartered in Marseille, France.

Tonghua Anruite Bio-Pharmaceutical Co., Ltd., established on 2014-08-07, The scope of business includes research and development of biomedical technology products and technical consultation in related fields,Technical Services,technology transfer;Biological product,medicine,Chinese patent medicine and raw materials,Pharmaceutical Intermediates,Diagnostic reagents,Research and Development of Medical Devices;Chemical Products(Free of Hazardous Chemicals),Equipment,metallic material,Building materials sales;Machinery and Equipment Leasing.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

LEVADURA BIOTECHNOLOGY INC. is an American private company that operates as a biotechnology company that develops yeast products using yeast cells in a fermentation process and produces cannabinoids.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Serono Genetics Institute SA, a subsidiary of Merck KGaA, is a French company located in Paris. The firm operates a biotechnology company specializing in synthetic DNA and genetic analysis. It was founded in 1989 by Pascal Brandys. Serono Genetics Institute SA was acquired by Serono SA on September 23, 2002 for $65.82 million.

Henan New Yangshao Biological Enzyme Co., Ltd., established on 2017-08-14, Business scope includes grain purchase and processing;Production of enzyme preparations and by-products,Sales;Purchase and sale of feed enzymes and feed;Import and export business of the company's products.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Regents of The University of Michigan provides administers bonds on behalf of the University. The company is headquartered in Ann Arbor, MI.

Cambria Biosciences is an innovative biotechnology company building a product pipeline\nfor neurological conditions such as Lou Gehrig��s disease and epilepsy. Cambria also\nemploys its chemical genetics platform to aid animal health and agricultural companies in\nadvancing their pipelines, differentiating their products and reducing the risks of field\nresistance through a precise understanding of their candidate products�� mode of action.